References
- Mol BWJ, Roberts CT, Thangaratinam S, et al. Pre-eclampsia. Lancet. 2016;387(10022):999–1011. doi: 10.1016/S0140-6736(15)00070-7.
- Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet. 2005;365(9461):785–799. doi: 10.1016/S0140-6736(05)17987-2.
- Pennica D, King KL, Shaw KJ, et al. Expression cloning of cardiotrophin 1, a cytokine that induces cardiac myocyte hypertrophy. Proc Natl Acad Sci U S A. 1995;92(4):1142–1146. doi: 10.1073/pnas.92.4.1142.
- Pennica D, Swanson TA, Shaw KJ, et al. Human cardiotrophin-1: protein and gene structure, biological and binding activities, and chromosomal localization. Cytokine. 1996;8(3):183–189. doi: 10.1006/cyto.1996.0026.
- López-Yoldi M, Moreno-Aliaga MJ, Bustos M. Cardiotrophin-1: a multifaceted cytokine. Cytokine Growth Factor Rev. 2015;26(5):523–532. doi: 10.1016/j.cytogfr.2015.07.009.
- Wollert KC, Taga T, Saito M, et al. Cardiotrophin-1 activates a distinct form of cardiac muscle cell hypertrophy. J Biol Chem. 1996;271(16):9535–9545. doi: 10.1074/jbc.271.16.9535.
- Latchman DS. Cardiotrophin-1 (CT-1): a novel hypertrophic and cardioprotective agent: cardiotrophin-1. Int J Exp Pathol. 1999;80(4):189–196. doi: 10.1046/j.1365-2613.1999.00114.x.
- Jougasaki M, Larsen AM, Cataliotti A, et al. Cardiotrophin-1 stimulates endothelin-1 via gp130 in vascular endothelial cells. Peptides. 2002;23(8):1441–1447. doi: 10.1016/s0196-9781(02)00078-5.
- Song K, Wang S, Huang B, et al. Plasma cardiotrophin-1 levels are associated With hypertensive heart disease: a Meta-Analysis. J Clin Hypertens (Greenwich). 2014;16(9):686–692. doi: 10.1111/jch.12376.
- Monserrat L, Lopez B, Gonzalez A, et al. Cardiotrophin-1 plasma levels are associated with the severity of hypertrophy in hypertrophic cardiomyopathy. Eur Heart J. 2011;32(2):177–183. doi: 10.1093/eurheartj/ehq400.
- ISUOG practice guidelines: use of doppler ultrasonography in obstetrics. Ultrasound Obstet Gynecol. 2013;41:233–239.
- ACOG Practice Bulletin No. 202: gestational hypertension and preeclampsia. Obstet Gynecol. 2019;133(1):1.
- Asai S, Saito Y, Kuwahara K, et al. The heart Is a source of circulating cardiotrophin-1 in humans. Biochem Biophys Res Commun. 2000;279(2):320–323. doi: 10.1006/bbrc.2000.3932.
- Natal C, Fortuño MA, Restituto P, et al. Cardiotrophin-1 is expressed in adipose tissue and upregulated in the metabolic syndrome. Am J Physiol Endocrinol Metab. 2008;294(1):E52–E60. doi: 10.1152/ajpendo.00506.2007.
- Jougasaki M. Cardiotrophin-1 in cardiovascular regulation. Adv Clin Chem. 2010;52:41–76.
- Pan J, Fukuda K, Saito M, et al. Mechanical stretch activates the JAK/STAT pathway in rat cardiomyocytes. Circ Res. 1999;84(10):1127–1136. doi: 10.1161/01.res.84.10.1127.
- Hishinuma S, Funamoto M, Fujio Y, et al. Hypoxic stress ınduces cardiotrophin-1 expression in cardiac myocytes. Biochem Biophys Res Commun. 1999;264(2):436–440. doi: 10.1006/bbrc.1999.1535.
- Pennica D, Shaw KJ, Swanson TA, et al. Cardiotrophin-1. Biological activities and binding to the leukemia inhibitory factor receptor/gp130 signaling complex. J Biol Chem. 1995;270(18):10915–10922. doi: 10.1074/jbc.270.18.10915.
- Lopez-Andres N, Fortuno MA, Diez J, et al. Vascular effects of cardiotrophin-1: a role in hypertension? J Hypertens. 2010;28(6):1261–1272. doi: 10.1097/HJH.0b013e328337fe42.
- Konii H, Sato K, Kikuchi S, et al. Stimulatory effects of cardiotrophin 1 on atherosclerosis. Hypertension. 2013;62(5):942–950. doi: 10.1161/HYPERTENSIONAHA.113.01653.
- Hung H-C, Lu F-H, Wu H-T, et al. Cardiotrophin-1 is inversely associated with obesity in non-diabetic individuals. Sci Rep. 2015;5:17438. doi: 10.1038/srep17438.
- Jung C, Fritzenwanger M, Figulla HR. Cardiotrophin-1 in adolescents: ımpact of obesity and blood pressure. Hypertension [Internet]. 2008;52:e6; author reply e7.